Pfizer hair loss drug Litfulo approved in UK Ruchika Sharma2 Nov 2023 11:30 AM ISTAlopecia areata is a condition where the immune system attacks hair follicles and causes hair to fall out, often in clumps.
Oral tofacitinib, novel alternative treatment for resistant alopecia areata among children Medha Baranwal27 Oct 2023 10:30 AM ISTChina: New research has demonstrated the safety and effectiveness of oral tofacitinib as a treatment option for pediatric alopecia areata (AA),...
USFDA accepts Sun Pharma NDA for alopecia areata drug Deuruxolitinib Ruchika Sharma6 Oct 2023 1:52 PM ISTMumbai: Sun Pharmaceutical Industries Ltd has announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application...
Up-titration of baricitinib may improve hair growth among patients with severe alopecia areata : JAMA Medha Baranwal6 Oct 2023 10:00 AM ISTUSA: A pooled analysis of the BRAVE-AA1 and BRAVE-AA2 trials revealed that severe alopecia areata patients not achieving successful regrowth of scalp...
European Commission approves ritlecitinib for severe Alopecia areata Dr. Kamal Kant Kohli23 Sept 2023 9:45 AM ISTThe European Commission has authorized the marketing of ritlecitinib for treatment of severe alopecia areata for adolescents and adults . ...
Pfizer Litfulo gets European Commission approval for adolescents, adults with severe alopecia areata Ruchika Sharma21 Sept 2023 3:30 PM ISTNew York: Pfizer Inc. has announced that the European Commission (EC) has granted marketing authorization for LITFULO (ritlecitinib) to treat...
Understanding Hair Loss: Causes, Symptoms, Prevention And Management - Dr Sunil Kumar Prabhu Dr Sunil Kumar Prabhu1 Aug 2023 12:32 PM IST .story .pasted-from-word-wrapper ul li { line-height: 25px;} Hair loss (alopecia) can affect just your scalp or your entire body, and it can be ...
Alopecia areata linked to higher autoimmunity, inflammation and mood disorders Aditi17 July 2023 8:00 PM ISTOriginal research published in The Journal of Dermatology entitled "Prevalence of autoimmune and inflammatory diseases and mental health conditions...
FDA approves first oral JAK inhibitor for treatment of alopecia areata in adolescents Medha Baranwal28 Jun 2023 8:00 PM ISTUSA: The US FDA (Food and Drug Administration) has approved ritlecitinib (Litfulo), a Janus kinase (JAK) inhibitor, for adults and adolescents with...
Hair loss drug: Pfizer Litfulo for adults, adolescents approved by USFDA Ruchika Sharma24 Jun 2023 11:30 AM ISTLITFULO is a kinase inhibitor which inhibits Janus kinase 3 (JAK3) and the tyrosine kinase expressed in hepatocellular carcinoma (TEC) family of...
Sun Pharma reports consolidated net profit of Rs 1984 crore in Q4 Ruchika Sharma27 May 2023 1:30 PM IST"Several of our businesses, including specialty, India and emerging markets have continued to progress well," Sun Pharma Managing Director Dilip...
USFDA halts Sun Pharma trials on dermatological drug Deuruxolitinib Ruchika Sharma2 May 2023 2:46 PM ISTThe company said it would work closely with the FDA to address the agency's concerns, which the drugmaker expected to be communicated within the next...
